Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kimi Shetty"'
Autor:
Madhur Jain, Rahul Sawant, Hitanshu Panchal, Anand S, Anupam Jena, Rahul Gupta, Karthik Kumar, Rajagopal Jambunathan, Sunil Modi, Ajit Mullasari, Nakul Sinha, Kimi Shetty, Pallavi Kawatra
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 19, Iss , Pp 200210- (2023)
Background: Low-density lipoprotein-cholesterol (LDL-C) is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD) progression. Although lipid lowering therapies remain the cornerstone of secondary ACSVD prevention, there exists
Externí odkaz:
https://doaj.org/article/277e304563d44a77829f3660fe526f06
Publikováno v:
Journal of Education and Health Promotion, Vol 8, Iss 1, Pp 211-211 (2019)
BACKGROUND: Attempts to put the available teaching–learning time to better use and address the needs of students by increasing active involvement led to the evolution of the flipped classroom (FC). It involves providing study resources for students
Externí odkaz:
https://doaj.org/article/509cd43e8b39480abb7be40e259fbf74
Autor:
Ashwani Mehta, B.B. Chanana, Anuj Sathe, Shreenivas Kumar, Bagirath Raghuraman, Shankar Kumar, Kimi Shetty, Gauri Billa, Pankaj Gupta
Publikováno v:
Indian Heart Journal. 74:S54
Autor:
Mangesh, Tiwaskar, Sanjay, Kalra, Ganapathi, Bantwal, Arpandev, Bhattacharya, Manisha, Sahay, Uday, Jadhav, Ameya, Joshi, A K, Das, Dinesh, Khullar, Manash, Baruah, Hitesh, Punyani, Kamal, Kishor, Kimi, Shetty, Jignesh, Ved
Publikováno v:
The Journal of the Association of Physicians of India. 69(4)
The concept of SGLT2-inhibition, once regarded as a non-physiological approach to glycemia control, now finds a foundational relevance in risk-modification for cardiovascular, kidney, and metabolic outcomes, spanning beyond type-2 diabetes. Major stu
Autor:
Kimi Shetty
Publikováno v:
Journal of Pharmacovigilance.